Silvergate Pharmaceuticals
Silvergate Pharmaceuticals is a U.S.-based specialty pharmaceutical company focused on development, manufacture and commercialization of age-appropriate oral dosage forms, including pediatric oral liquids and powder-for-reconstitution products. The company has received multiple FDA approvals for oral solution and powder formulations and operates programs for regulatory compliance, supplier relationships and pharmacy distribution.
Industries
Nr. of Employees
small (1-50)
Silvergate Pharmaceuticals
Englewood, Colorado, United States
Patents
Products
Lisinopril oral solution (pediatric)
An oral solution formulation of lisinopril developed and made available for pediatric patients; associated with an FDA approval for pediatric use.
Enalapril powder-for-reconstitution (pediatric)
A powder-for-reconstitution formulation of enalapril intended for pediatric hypertension; described in regulatory approval communications.
Methotrexate ready-to-use oral solution (oncology, pediatric)
A ready-to-use oral solution formulation of methotrexate made available for pediatric oncology use.
Lisinopril oral solution (pediatric)
An oral solution formulation of lisinopril developed and made available for pediatric patients; associated with an FDA approval for pediatric use.
Enalapril powder-for-reconstitution (pediatric)
A powder-for-reconstitution formulation of enalapril intended for pediatric hypertension; described in regulatory approval communications.
Methotrexate ready-to-use oral solution (oncology, pediatric)
A ready-to-use oral solution formulation of methotrexate made available for pediatric oncology use.
Services
Facilitation of medication access and distribution through pharmacy partnerships, including cross-border sourcing options.
Bringing approved oral solutions and powder products to market and supplying them to healthcare providers and pharmacies.
Facilitation of medication access and distribution through pharmacy partnerships, including cross-border sourcing options.
Bringing approved oral solutions and powder products to market and supplying them to healthcare providers and pharmacies.
Expertise Areas
- Pediatric formulation development
- Oral liquid and powder-for-reconstitution dosage forms
- Regulatory affairs and FDA approvals
- CMC development and scale-up
Key Technologies
- Oral liquid formulation
- Powder-for-reconstitution formulation
- Ready-to-use oral solution preparation
- Pediatric dosing/formulation methods
News & Updates
FDA approval announced for a pediatric oral solution formulation of lisinopril.
Regulatory approvals announced for an enalapril powder-for-reconstitution oral solution and new pediatric indications.
Announcement of availability for a ready-to-use methotrexate oral solution formulation intended for pediatric oncology use.
FDA approval announced for a pediatric oral solution formulation of lisinopril.
Regulatory approvals announced for an enalapril powder-for-reconstitution oral solution and new pediatric indications.
Announcement of availability for a ready-to-use methotrexate oral solution formulation intended for pediatric oncology use.